ACT |
artemisinin combination therapy |
ADI |
acceptable daily intake |
ALA |
alpha-linolenic acid; |
API |
active pharmaceutical ingredients |
ARA |
arachidonic acid |
ATP |
adenosine triphosphate |
BBB |
blood–brain barrier |
Cas9 |
CRISPR-associated protein 9 |
CD44 |
cluster of differentiation 44; |
CMC |
critical micellar concentration |
CPP |
cell penetrating peptides |
CRISPR |
clustered regularly interspaced short palindromic repeats |
DCC |
dicyclohexylcarbodiimide |
DHA |
docosahexaenoic acid |
DMAP |
4-(dimethylamino)pyridine |
DOTAP |
1,2-dioleoyl-3-trimethylammonium-propane chloride |
DPA |
docosapentaenoic acid |
DPPC |
1,2-dipalmitoyl-sn-glycero-3-phosphocholine |
DSC |
differential scanning calorimetry |
DSPE-PEG2000
|
1,2-distearoyl-sn-glycero-3-phosphoethanol-amine-N-amino(polyethylene glycol)2000
|
ELISA |
enzyme-linked immunosorbent assay |
EPR |
enhanced permeability and retention |
ESR |
electron spin resonance |
EV |
extracellular vesicles |
FDA |
US Food and Drug Administration |
FTIR |
Fourier-transform infrared |
GI |
gastrointestinal |
GIXD |
grazing incidence X-ray diffraction |
GPC |
glycerophosphocholine |
GRAS |
generally recognized as safe |
HA |
hyaluronic acid |
HLD |
hydrophilic–lipophilic deviation |
HSC |
hepatic stellate cells |
HSPC |
hydrogenated soybean phosphatidylcholine |
i.m. |
intramuscular |
i.v. |
intravenous |
ITC |
isothermal titration calorimetry |
LLOD |
lower limit of detection |
LPE |
lyso-phosphatidylethanolamine |
miRNA |
micro ribonucleic acid |
ML-I |
mistletoe-lectin-I |
MM |
mixed micelles |
MM-DDS |
mixed micellar drug delivery systems |
MNBA |
2-methyl-6-nitrobenzoic anhydride |
MPS |
mononuclear phagocytic system |
mRNA |
messenger ribonucleic acid |
MTP-PE |
muramyl tripeptide |
NAFLD |
non-alcoholic fatty liver disease |
NASH |
non-alcoholic steatohepatitis |
NIR |
near-infrared |
NSAID |
non-steroidal anti-inflammatory drugs |
o/w |
oil-in-water |
OXIL |
oxidation-responsive liposomes |
OxPL |
oxidized phospholipids |
PA |
phosphatic acid |
PC |
phosphatidylcholine |
PE |
phosphatidylethanolamine |
PEG |
polyethylene glycol |
PG |
phosphatidylglycerol |
PI |
phosphatidylinositol |
PLA1 |
phospholipase A1 (alternatively A2, B, C, D) |
PLGA |
poly(lactide-co-glycolide) |
POPC |
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine |
PRC |
Phospholipid Research Center Heidelberg |
PRR |
pattern-recognition-receptor |
PS |
phosphatidylserine |
PUFA |
polyunsaturated fatty acids |
RNA |
ribonucleic acid |
s.c. |
subcutaneous |
SANP |
self-assembling nanoparticle |
SAXS |
small angle X-ray scattering |
SEDDS |
self-emulsifying drug delivery systems |
siRNA |
small interfering ribonucleic acid |
SLN |
solid-lipid nanoparticles |
SM |
sphingomyelin |
SNEDDS |
self nano-emulsifying drug delivery systems |
SPM |
specialized pro-resolving mediators |
TAM |
tumor-associated macrophages |
TB |
tuberculosis |
TEL |
tetraether lipid |
TRXF |
total reflection X-ray fluorescence |
TSL |
temperature-sensitive liposomes |
USL |
ultrasound-sensitive liposomes |
USP |
United States Pharmacopeia |
w/o |
water-in-oil |
WHO |
World Health Organization |